Device Trial Radar · NCT05771844
Home Sleep Therapy for Older Adults With MCI
Last checked: Nov 20, 2026Latest source record: Feb 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Feb 8, 2023
Primary completion
Jun 1, 2026
Study completion Jun 1, 2026
Sponsor
- Lead sponsor
- Brain Electrophysiology Laboratory CompanyNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Institute on Aging (NIA); Wake Forest University
- First posted
- Mar 16, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in people with mild cognitive impairment via home use sleep therapy device (SleepWISP) as well as learn about biomarkers associated with Alzheimer disease (AD). The clinical trial aims to answer the following main questions: 1. Whether the non-invasive transcranial electrical stimulation (TES) delivered by SleepWISP could provide short-term enhancement of deep sleep in a single night in the target population. 2. Whether TES delivered by SleepWISP could enhance deep sleep over multiple nights in the target population. 3. Whether enhance on deep sleep could improve memory performance in the target population. Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep along with an actigraphy watch that measures their movement throughout the day. In addition, blood samples or nasal swab assays will be collected from participants multiple times during the study.
Conditions
- Mild Cognitive Impairment
- Sleep
- Transcranial Electrical Stimulation
- Machine Learning
- Memory
Interventions
Transcranial Electrical StimulationDevice
Oscillating electrical current
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device UsabilityTime frame: Collected each day they use the Sleep WISP system, for three sessions over 10 days during Phase I of the study.
2 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Wake Forest University
Winston-Salem, North Carolina · Not yet recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.